ArticleJournal of oncology2022

NXPH4 Used as a New Prognostic and Immunotherapeutic Marker for Muscle-Invasive Bladder Cancer.

Zhiming Gui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.